Abstract

EP.11E.05 Outpatient Treatment Strategies for Grade 3-4 Immune-Mediated Hepatitis in Patients with Lung Cancer

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Real-world experience of immune-mediated hepatitis in Danish lung cancer patient using PD1 inhibitors
L.E Lauritsen ... K Skougaard
Annals of Oncology | VOL. 30
L.E Lauritsen, et. al.L.E Lauritsen ... K Skougaard
01 Dec 2019
Hepatitis-related adverse events associated with immune checkpoint inhibitors in cancer patients: an observational, retrospective, pharmacovigilance study using the FAERS database.
Zhiwen Fu ... Shijun Li
Frontiers in pharmacology | VOL. 15
Zhiwen Fu, et. al.Zhiwen Fu ... Shijun Li
01 Jan 2024
Liver toxicity as a limiting factor to the increasing use of immune checkpoint inhibitors.
Eleonora De Martin ... Olivier Rosmorduc
JHEP Reports | VOL. 2
Eleonora De Martin, et. al.Eleonora De Martin ... Olivier Rosmorduc
11 Aug 2020
Immune-mediated hepatitis induced by immune checkpoint inhibitors: Current updates and future perspectives.
Zherui Liu ... Yun Zhu
Frontiers in Pharmacology | VOL. 13
Zherui Liu, et. al.Zherui Liu ... Yun Zhu
09 Jan 2023
View more papers

More From: Journal of Thoracic Oncology

Paper Title
Journal
Date
Author
Screening for Lung Cancer, Overdiagnosis, and Healthcare Utilization: A Nationwide Population-Based Study
So Yeon Kim ... Young Sik Park
Journal of Thoracic Oncology | VOL. -
So Yeon Kim, et. al.So Yeon Kim ... Young Sik Park
01 Dec 2024
The use of investigator-assigned subjective or judgmental efficacy and toxicity reporting in early phase clinical trials of lung cancer treatments
William J Phillips ... D Ross Camidge
Journal of Thoracic Oncology | VOL. -
William J Phillips, et. al.William J Phillips ... D Ross Camidge
01 Dec 2024
Sex and common germline variants impact the toxicity profile and pharmacokinetics of alectinib: a nation-wide cohort study in patients with ALK-positive non-small cell lung cancer
Niels Heersche ... G.D Marijn Veerman
Journal of Thoracic Oncology | VOL. -
Niels Heersche, et. al.Niels Heersche ... G.D Marijn Veerman
29 Nov 2024
Differentiating Separate Primary Lung Adenocarcinomas From Intrapulmonary Metastases With Emphasis on Pathological and Molecular Considerations: Recommendations From the International Association for the Study of Lung Cancer Pathology Committee
Teh-Ying Chou ... Wendy A Cooper
Journal of Thoracic Oncology | VOL. -
Teh-Ying Chou, et. al.Teh-Ying Chou ... Wendy A Cooper
22 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.